Published in Pediatr Cardiol on November 20, 2003
Percutaneous closure of atrial septal defects in spontaneously breathing children under deep sedation: a feasible and safe concept. Pediatr Cardiol (2013) 0.76
(S)-(+)-Ketamine hydro-chloride. Acta Crystallogr Sect E Struct Rep Online (2008) 0.75
Ketamine--its pharmacology and therapeutic uses. Anesthesiology (1982) 3.61
Sedation and analgesia for procedures in children. N Engl J Med (2000) 1.46
Comparative pharmacology of the ketamine isomers. Studies in volunteers. Br J Anaesth (1985) 1.42
Pharmacology of ketamine isomers in surgical patients. Anesthesiology (1980) 1.05
The use of ketamine hydrochloride anaesthesia for radiotherapy in young children. Br J Anaesth (1973) 0.93
[Studies using S-(+)-ketamine on probands. Endocrine and circulatory reactions, recovery and dream experiences]. Anaesthesist (1992) 0.91
[The action of S-(+)-ketamine on serum catecholamine and cortisol. A comparison with ketamine racemate]. Anaesthesist (1992) 0.91
[Recovery and psychomimetic reactions following S-(+)-ketamine]. Anaesthesist (1997) 0.91
Comparative pharmacology of the optical isomers of ketamine in mice. Eur J Pharmacol (1978) 0.90
Hemodynamic effects of ketamine in children with congenital heart disease. Anesth Analg (1984) 0.87
Pulmonary and systemic hemodynamic responses to ketamine in infants with normal and elevated pulmonary vascular resistance. Anesthesiology (1985) 0.83
Ketamine anaesthesia for cardiac catheterisation. Anaesthesia (1972) 0.79
[From the racemate to the eutomer: (S)-ketamine. Renaissance of a substance?]. Anaesthesist (1997) 0.79
[Total i.v. anesthesia with S-(+)-ketamine in orthopedic geriatric surgery. Endocrine stress reaction, hemodynamics and recovery]. Anaesthesist (1994) 0.78
[Ketamine racemate versus S-(+)-ketamine with or without antagonism with physostigmine. A quantitative EEG study on volunteers]. Anaesthesist (1994) 0.78
[Psychometric changes as well as analgesic action and cardiovascular adverse effects of ketamine racemate versus s-(+)-ketamine in subanesthetic doses]. Anaesthesist (1994) 0.76
Psychological changes in children after anaesthesia: a comparison between halothane and ketamine. Acta Anaesthesiol Scand (1977) 0.75
Ketamine for pediatric cardiac anesthesia. Anaesthesist (1976) 0.75
Comparison of oral triclofos, diazepam and flunitrazepam as premedicants in children undergoing otolaryngological surgery. Br J Anaesth (1980) 0.75
[S-(+)-ketamine. The beginning of a new ketamine era?]. Anaesthesist (1992) 0.75
Rational use of ketamine as an anaesthetic. Proc R Soc Med (1971) 0.75
[Arousal in various analgosedation schedules]. Klin Wochenschr (1991) 0.75
The effect of ketamine on pulmonary artery pressure. An experimental and clinical study. Anaesthesia (1974) 0.75
Selective indications for ketamine anaesthesia. Proc R Soc Med (1971) 0.75
Dynamic analyses of the expression of the HISTONE::YFP fusion protein in arabidopsis show that syncytial endosperm is divided in mitotic domains. Plant Cell (2001) 2.72
Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood (2000) 2.39
The small genome of Arabidopsis contains at least nine expressed beta-tubulin genes. Plant Cell (1992) 2.31
Transcatheter closure as standard treatment for most interatrial defects: experience in 200 patients treated with the Amplatzer Septal Occluder. Cardiol Young (1999) 2.26
Anomalous origin of the left coronary artery from the pulmonary artery in adults. J Card Surg (1995) 2.16
A multicenter study of treatment of primary CNS lymphoma. Neurology (2002) 2.04
Comparison of results and complications of surgical and Amplatzer device closure of atrial septal defects. J Thorac Cardiovasc Surg (1999) 1.97
The small genome of Arabidopsis contains at least six expressed alpha-tubulin genes. Plant Cell (1992) 1.93
Cerebral oxygen monitoring during neonatal cardiopulmonary bypass and deep hypothermic circulatory arrest. Thorac Cardiovasc Surg (2002) 1.93
Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia (2006) 1.88
Value of endobiliary brush cytology and biopsies for the diagnosis of malignant bile duct stenosis: results of a prospective study. Gastrointest Endosc (1995) 1.86
Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol (1997) 1.86
Noninvasive quantitative imaging of protein-protein interactions in living subjects. Proc Natl Acad Sci U S A (2002) 1.85
Incidence of atrial flutter/fibrillation in adults with atrial septal defect before and after surgery. Ann Thorac Surg (1999) 1.84
Circulatory support with pneumatic paracorporeal ventricular assist device in infants and children. Ann Thorac Surg (1998) 1.82
Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. J Clin Oncol (1997) 1.77
Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia (2006) 1.72
Primary thyroid lymphoma is a heterogeneous disease. J Clin Endocrinol Metab (2002) 1.70
Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA). Blood (1998) 1.65
Repair of coarctation of the aorta in adults: the fate of systolic hypertension. Ann Thorac Surg (1996) 1.64
Polycomb group genes control pattern formation in plant seed. Curr Biol (2001) 1.56
The MINE regimen as intensive salvage chemotherapy for relapsed and refractory Hodgkin's disease. Ann Oncol (1995) 1.52
Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria. Leukemia (2007) 1.51
Adult cirrhotic liver explants: precancerous lesions and undetected small hepatocellular carcinomas. Gastroenterology (1996) 1.51
Correction of complete atrioventricular septal defects with the double-patch technique and cleft closure. Ann Thorac Surg (1996) 1.51
[Severe complications caused by inattention to endocarditis prevention during dental procedures in adults with congenital heart abnormalities]. Dtsch Med Wochenschr (2000) 1.47
Renal function after cardiopulmonary bypass surgery in cyanotic congenital heart disease. Int J Cardiol (2000) 1.47
Development of pulmonary arteries after central aortopulmonary shunt in newborns. Ann Thorac Surg (2001) 1.45
Plasma endothelin-1 in patients with left-to-right shunt. Am Heart J (1995) 1.45
Transcatheter closure of multiple atrial septal defects. Initial results and value of two- and three-dimensional transoesophageal echocardiography. Eur Heart J (2000) 1.44
[Isolated myocardial noncompaction in childhood-case report and review of the literature]. Z Kardiol (2003) 1.40
Cell fate determination by the cell wall in early fucus development. Science (1994) 1.39
Masked left ventricular restriction in elderly patients with atrial septal defects: a contraindication for closure? Catheter Cardiovasc Interv (2001) 1.39
The unstable region of Streptomyces ambofaciens includes 210 kb terminal inverted repeats flanking the extremities of the linear chromosomal DNA. Mol Microbiol (1996) 1.37
Anomalous origin of the left coronary artery from the pulmonary artery. Early results with direct aortic reimplantation. J Thorac Cardiovasc Surg (1994) 1.33
Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr (2001) 1.31
Maternal control of seed development. Semin Cell Dev Biol (2001) 1.30
Altered homologous and heterologous gap-junctional intercellular communication in primary human liver tumors associated with aberrant protein localization but not gene mutation of connexin 32. Int J Cancer (1994) 1.29
Left ventricular conditioning in the elderly patient to prevent congestive heart failure after transcatheter closure of atrial septal defect. Catheter Cardiovasc Interv (2005) 1.29
Primary cardiac tumours: when is surgery necessary? Eur J Cardiothorac Surg (2001) 1.27
Mutations in the pilz group genes disrupt the microtubule cytoskeleton and uncouple cell cycle progression from cell division in Arabidopsis embryo and endosperm. Eur J Cell Biol (1999) 1.23
Mantle cell lymphoma: a retrospective study of 121 cases. Leukemia (1998) 1.22
Left and right ventricular adaptation to right ventricular overload before and after surgical repair of tetralogy of Fallot. Am J Cardiol (1982) 1.21
Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome. Blood (1997) 1.19
A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ('Ki-1 lymphoma'). Br J Haematol (1989) 1.18
Contribution of endoscopy to diagnosis and treatment of tumors of the ampulla of Vater. Cancer (1989) 1.18
Morphology of perforated atrial septal aneurysm suitable for closure by transcatheter device placement. Heart (2000) 1.15
Transcatheter closure of atrial septal defects without fluoroscopy: feasibility of a new method. Circulation (2000) 1.14
Expression and tumorigenicity of the Epstein-Barr virus BARF1 gene in human Louckes B-lymphocyte cell line. Cancer Res (1994) 1.14
Treatment of atrial septal defects in symptomatic children aged less than 2 years of age using the Amplatzer septal occluder. Cardiol Young (2000) 1.14
Rearrangement of CCND1 (BCL1/PRAD1) 3' untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemias. Blood (1994) 1.13
Alpha-tubulin gene family of maize (Zea mays L.). Evidence for two ancient alpha-tubulin genes in plants. J Mol Biol (1992) 1.13
Benefits of surgical repair of coarctation of the aorta in patients older than 50 years. Ann Thorac Surg (2001) 1.13
Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications. Leukemia (2012) 1.12
Further experience with the two-stage anatomic correction of simple transposition of the great arteries. Thorac Cardiovasc Surg (1981) 1.12
Cellular effects of olomoucine, an inhibitor of cyclin-dependent kinases. Biol Cell (1995) 1.12
Radiofrequency-assisted "reconstruction" of the right ventricular outflow tract in muscular pulmonary atresia with ventricular septal defect. Br Heart J (1993) 1.12
EGF receptor amplification and expression in human brain tumours. Eur J Cancer (1992) 1.12
Regulation of human heart contractility by essential myosin light chain isoforms. J Clin Invest (1996) 1.12
Chemical pathology in brain white matter of recently detoxified alcoholics: a 1H magnetic resonance spectroscopy investigation of alcohol-associated frontal lobe injury. Alcohol Clin Exp Res (2001) 1.09
Comparison of transthoracic three dimensional echocardiography with magnetic resonance imaging in the assessment of right ventricular volume and mass. Heart (1997) 1.09
Accelerated degeneration of allografts in the first two years of life. Ann Thorac Surg (1995) 1.09
Challenges encountered during closure of atrial septal defects. Pediatr Cardiol (2005) 1.08
[Interventional treatment of congenital heart defects in infants with a body weight up to 2,500 grams]. Z Kardiol (2000) 1.08
A modified repair technique for tricuspid incompetence in Ebstein's anomaly. J Thorac Cardiovasc Surg (1998) 1.08
Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas. Oncogene (2006) 1.08
Primary pulmonary non-Hodgkin's lymphomas. Histopathology (1995) 1.06
Maldevelopment of conotruncal and aorto-pulmonary septum with absent left central pulmonary artery: anatomical and clinical implications. Br Heart J (1994) 1.06
Burkitt-like lymphomas in AIDS patients: characterization within a series of 103 human immunodeficiency virus-associated non-Hodgkin's lymphomas. Burkitt's Lymphoma Study Group. J Clin Oncol (1998) 1.06
Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients. Pediatr Transplant (2008) 1.06
Aggressive primary gastrointestinal lymphomas: review of 91 patients treated with the LNH-84 regimen. A study of the Groupe d'Etude des Lymphomes Agressifs. Am J Med (1991) 1.05
The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab. Leukemia (2008) 1.05
Position dependent control of cell fate in the Fucus embryo: role of intercellular communication. Development (1998) 1.03
Isolation and characterization of a novel gamma-hexachlorocyclohexane-degrading bacterium. J Bacteriol (1996) 1.03
Self-fabricated fenestrated Amplatzer occluders for transcatheter closure of atrial septal defect in patients with left ventricular restriction: midterm results. Clin Res Cardiol (2006) 1.02
Renal impairment in patients with long-standing cyanotic congenital heart disease. Acta Paediatr (1998) 1.02
Characterization of four new beta-tubulin genes and their expression during male flower development in maize (Zea mays L.). Plant Mol Biol (1994) 1.02
Endothelial cell marker expression in dysplastic lesions of the liver: an immunohistochemical study. J Hepatol (2001) 1.02
Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas. Blood (1994) 1.01
A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation. Leukemia (2007) 1.00
A clinicopathological study of nodal marginal zone B-cell lymphoma. A report on 21 cases. Histopathology (2006) 1.00